Bulletin
Investor Alert

Cyclerion Therapeutics Inc.

NAS: CYCN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Cyclerion Therapeutics Inc.

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 5:29 p.m.

CYCN
/zigman2/quotes/207301221/composite

$

0.58

Change

+0.03 +4.99%

Volume

Volume 100

Quotes are delayed by 20 min

/zigman2/quotes/207301221/composite

Previous close

$ 0.58

$ 0.55

Change

-0.03 -4.97%

Day low

Day high

$0.55

$0.62

Open

52 week low

52 week high

$0.50

$4.86

Open
Insider Activity Individual

Mark G. Currie

Transactions

Date Shares Transaction Value
12/28/2020 20,107   Disposition at $3.01 per share. 60,523
12/30/2019 25,000   Disposition at $2.48 per share. 62,000
12/27/2019 25,000   Disposition at $2.55 per share. 63,750
04/02/2019 270,107   Acquisition at $14.81 per share. 4,000,284
04/01/2019 51,648   Award at $0 per share. 0
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

Officers and Executives

Dr. Peter M. Hecht
Chief Executive Officer & Director
Ms. Cheryl Gault
Chief Operating Officer
Ms. Anjeza Gjino
Chief Financial Officer
Mr. Kevin Durfee
Vice President-Information Technology & Facilities
Dr. Andreas Eugen Busch
Chief Scientific Officer
Dr. G. Todd Milne
Senior Vice President-Corporate Development
Dr. Jennifer Chickering
Vice President-Clinical Strategy
Ms. Marsha H. Fanucci
Chairman
Dr. Errol B. de Souza
Independent Director
Ms. Stephanie Lovell
Independent Director
Dr. Michael E. Mendelsohn
Independent Director
Dr. Ole Isacson
Independent Director
Mr. Terrance G. McGuire
Independent Director
Mr. George H. Conrades
Independent Director
Link to MarketWatch's Slice.